The Role of Polymorphonuclear Leukocyte Trafficking in the Perpetuation of Inflammation During Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The inflammatory bowel diseases (IBDs; Crohn's disease, and ulcerative colitis) are chronically relapsing inflammatory disorders of the intestine and/or colon. The precise etiology of IBD remains unclear, but it is thought that a complex interplay between various factors including genetic predisposition, the host immune system, and the host response to luminal microbes play a role in disease pathogenesis. Furthermore, numerous lines of evidence have implicated the accumulation of large numbers of polymorphonuclear leukocyte (PMN) in the mucosa and epithelial crypts of the intestine as a hallmark of the active disease phase of IBD. Massive infiltration of PMNs is thought to be instrumental in the pathophysiology of IBD with the degree of PMN migration into intestinal crypts correlating with patient symptoms and mucosal injury. Specifically, migrated PMN have been implicated in the impairment of epithelial barrier function, tissue destruction through oxidative and proteolytic damage, and the perpetuation of inflammation through the release of inflammatory mediators. This review highlights the multifactorial role of PMN egress into the intestinal mucosa in the pathogenesis of IBD because it represents an important area of research with therapeutic implications for the amelioration of the symptoms associated with IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950 · cited 2×
“a2-macroglobulin, facilitating dysregulated proteolysis of the mucosal interstitium and the intestinal epithelium by phagocyte-derived elastase.(60) Also, PMN use the MPO–H2O2–chloride system to generate reactive oxidants, activating metalloproteinases that can in turn go on to hydrolyze both the a1-protease inhibitor…”
BackgroundInfection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo
Yipp, B. G., Petri, B., Salina, D., Jenne, C. N., Scott, B. N. V., Zbytnuik, L. D., Pittman, K., Asaduzzaman, M., Wu, K., Meijndert, H. C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2847 · Cited by 1,169
Tumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063 · cited 1×
“and increased PMN-mediated release of reactive oxygen metabolites.(81) IL-1a and IL-1b can also exert immunomodulatory effects on PMN, leading to enhanced priming and activation, and therefore, these PMN-produced cytokines may also contribute to disease pathogenesis observed during a dysregulated immune response.”
BackgroundBeneficial suicide: why neutrophils die to make NETs
Brinkmann, V., & Zychlinsky, A. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1710 · Cited by 937 · cited 3×
“Furthermore, in the presence of a halide such as Cl2, superoxide radicals are readily converted into hypochlorous acid (HOCl) or N-chloramines (RNHCls) in reactions catalyzed by the PMN granular enzyme myeloperoxidase (MPO).46 Hypochlorous acid is both a chlorinating and oxidizing agent that is 100 to 1000 times more…”
BackgroundMechanisms That Regulate the Function of the Selectins and Their Ligands
VESTWEBER, D., & BLANKS, J. E. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.181 · Cited by 932
Campbell, E. L., Louis, N. A., Tomassetti, S. E., Canny, G. O., Arita, M., Serhan, C. N., & Colgan, S. P. (2007) · The FASEB Journal · doi:10.1096/fj.07-8473com · Cited by 205 · cited 1×
“In addition, antibody-mediated blockage of CD55, which also localizes to the luminal surface of the intestinal epithelium, results in the accumulation of PMN at the apical epithelial surface.(39,40) Most recently, a role for the epithelial transmembrane glycoprotein CD44v6 in the detachment of PMN from the apical aspe…”
BackgroundSelf-citationThe role of neutrophil apoptosis in influencing tissue repair
Sylvia, C. J. (2003) · Journal of Wound Care · doi:10.12968/jowc.2003.12.1.26458 · Cited by 62 · cited 1×
“Therefore, constant transmigration of PMN into the inflamed intestinal mucosa, during dysregulated immune responses, where the local environment mimics the acute phase of inflammation, results in a bias toward release of PMN-derived ROS and proinflammatory cytokines and not the PMN-mediated release of antiinflammatory…”
Background
Cited by
Le Berre, C., Honap, S., & Peyrin-Biroulet, L. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00966-2 · Cited by 1,643
Immunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Li, G., Lin, J., Zhang, C., Gao, H., Lu, H., Gao, X., Zhu, R., Li, Z., Li, M., & Liu, Z. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1968257 · Cited by 472
Mycotoxin: Its Impact on Gut Health and Microbiota
Liew, W.-P.-P., & Mohd-Redzwan, S. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00060 · Cited by 470
p53, cancer and the immune response
Blagih, J., Buck, M. D., & Vousden, K. H. (2020) · Journal of Cell Science · doi:10.1242/jcs.237453 · Cited by 333
“The consequential increase in TP53 mutations can further contribute to IBD and eventual malignant progression (Brazil et al., 2013; ButinIsraeli et al., 2019; Campregher et al., 2008; Hofseth et al., 2003; Hussain et al., 2000).”
Background
Metadata
- Authors
- Brazil, J. C., Louis, N. A., & Parkos, C. A.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06
- Volume
- 19
- Issue
- 7
- Pages
- 1556-1565
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2026861097
- Cited by
- 156
- References
- 8
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.